Home » Topics » Disease categories and therapies » Urology

Urology
RSS

New therapeutic agents for renal diseases in early development at Astellas Pharma

Sep. 8, 2005

Update on the potential of SVT-40776 as a novel treatment for overactive bladder

Sep. 7, 2005

GABA-B receptor agonists prepared and tested at Bayer

Sep. 1, 2005

Bayer claims novel vanilloid VR1 receptor antagonists for urological disorders

Aug. 25, 2005

Darifenacin improves quality of life of patients with overactive bladder

Aug. 18, 2005

Novel therapeutics for fibroproliferative diseases reported by Scios

Aug. 16, 2005

Clinical data confirm the efficacy of solifenacin in overactive bladder

Aug. 16, 2005

TH-070 begins phase III study for BPH

Aug. 10, 2005

Interim safety results of pivotal study of NX-1207 for BPH

Aug. 10, 2005

Phase IIb studies begin for PT-141 for erectile dysfunction

Aug. 9, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...